SatiSilver™ & SatiGreen™ Now Available for Purchase
VANCOUVER, March 21, 2019 /CNW/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSXV: HVT; OTCQX: HRVOF), through it's wholly-owned subsidiary United Greeneries Ltd. ("United Greeneries"), today announced that it has completed its first shipment to Shoppers Drug Mart of Satipharm branded cannabis.
Satipharm branded cannabis is now available for purchase on the Shoppers Drug Mart cannabis web portal.
In this first shipment under the terms of the supply agreement announced on Monday March 18th, Harvest One through United Greeneries has provided Shoppers with SatiSilver™ (Great White Shark) with a moderate THC content, and SatiGreen™ (CBD Tonic) with a 1:1 ratio of THC:CBD.
"We have an incredibly dedicated and driven team at Harvest One who are all focused on execution of the strategy of being a leading health, wellness, and self-care company in the cannabis sector" said Grant Froese, CEO of Harvest One. "Just days after announcing our supply agreement with Shoppers Drug Mart, we are proud to see that our product is already available for medical consumers. Harvest One continues to focus on execution of our previously announced plans from construction of facilities, launching new products, and completing our pending transaction with Delivra™ which will bring more brands and products into our portfolio across Canada and around the world" he added.
ABOUT HARVEST ONE CANNABIS INC.
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer), and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
SOURCE Harvest One Cannabis Inc.
For further information: Colin Clancy, Investor Relations, firstname.lastname@example.org, 1-877-915-7934; Will Stewart, Senior Vice President, Corporate and Public Affairs, WStewart@HarvestOne.com, 416-899-9422